Show Eula
Quick Tour
My CME
My Folder
Login
Specialty
Decision Tools
Drug Reference
Guidelines
Trials
More
Conference Data
Suggested CME
X
go
Specialty
HIV
Management of Specific Disease States
Parasitic Infections
Summary
Introduction
Pneumocystis jirovecii
Pneumonia
Epidemiology
Clinical Manifestations
Diagnosis
Preventing Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Toxoplasmosis
Epidemiology
Clinical Manifestations
Diagnosis
Preventing Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Cryptosporidiosis
Epidemiology
Clinical Manifestations
Diagnosis
Prevention of Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Microsporidiosis
Epidemiology
Clinical Manifestations
Diagnosis
Prevention of Exposure to the Pathogen
Primary Prophylaxis
Treatment
Secondary Prophylaxis
Malaria
Epidemiology
Clinical Manifestations
Diagnosis
Preventing Exposure
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Chagas Disease
Epidemiology
Clinical Manifestations
Diagnosis
Preventing Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Leishmaniasis
Epidemiology
Clinical Manifestations
Diagnosis
Preventing Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Cyclosporiasis
Epidemiology
Clinical Manifestations
Diagnosis
Prevention of Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Cystoisosporiasis
Epidemiology
Clinical Manifestations
Diagnosis
Prevention of Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Strongyloidiasis
Epidemiology
Clinical Manifestations
Diagnosis
Prevention of Exposure to the Pathogen
Primary Prophylaxis
Secondary Prophylaxis
Treatment
Initiating ART in Patients With Acute Parasitic Infections
Primary Care Essentials
Supporting Assets
References
Jointly Provided by Clinical Care Options, LLC, and:
more information about our provider
Save
Share
Print
Email
Previous
Next
Parasitic Infections in HIV-Infected Patients
Authors: José M. Miró, MD, PhD; Miriam J. Álvarez-Martínez, MD, PhD (
More Info
)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 4/1/16
(
What's New
)
Summary
OIs remain common in settings where ART is not widely available, in patients with undiagnosed HIV disease, and in patients who fail therapy due to drug resistance, nonadherence, or intolerance
Guidelines on preventing and treating OIs in HIV-infected patients are published by the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America
(Management Guidelines)
[
CDC OI
]
and the Grupo de Estudio de Sida
(Management Guidelines)
[
Panel 2008a
]
(Management Guidelines)
[
Panel 2008b
]
Action required
Login
now to access all of your entitled content
or
View additional options to gain access to this content
Previous
Next